Mayo Clinic

Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk (2021) Kapoor PM, Mavaddat N, Choudhury PP, Wilcox AN, Lindström S, Behrens S, Michailidou K, et al. Journal article Corticotroph tumor progression after bilateral adrenalectomy (Nelson's syndrome): systematic review and expert consensus recommendations (2021) Reincke M, Albani A, Assie G, Bancos I, Brue T, Buchfelder M, Chabre O, et al. Journal article, Review article Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy (2021) Furlanetto J, Möbus V, Schneeweiss A, Rhiem K, Tesch H, Blohmer JU, Lübbe K, et al. Journal article Idecabtagene vicleucel in relapsed and refractory multiple myeloma (2021) Munshi NC, Anderson LD, Shah N, Madduri D, Berdeja J, Lonial S, Raje N, et al. Journal article Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia (2021) Trpkov K, Williamson SR, Gill AJ, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, et al. Journal article Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus Workshop. (2021) Cho Y, Tong A, Craig JC, Mustafa RA, Chapman A, Perrone RD, Ahn C, et al. Journal article Incorporation of quantitative MRI in a mode to predict temporal lobe epilepsy surgery outcome (2021) Morita-Sherman M, Li M, Joseph B, Yasuda C, Vegh D, De Campos BM, Alvim MKM, et al. Journal article Impact of Consensus Definitions on Identification of Glomerular Lesions by Light and Electron Microscopy (2021) Haas M, Mirocha J, Amann KU, Bajema IM, Barisoni L, Becker JU, Jennette JC, et al. Journal article Genetic and epigenetic characterization of posterior pituitary tumors (2021) Schmid S, Solomon DA, Perez E, Thieme A, Kleinschmidt-Demasters BK, Giannini C, Reinhardt A, et al. Journal article Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer (2021) Konecny GE, Hendrickson AE, Davidson TM, Winterhoff BJ, Ma S, Mahner S, Sehouli J, et al. Journal article